Literature DB >> 18074495

The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event.

José I Botella-Carretero1, Francisco Alvarez-Blasco, M Angeles Martinez-García, Manuel Luque-Ramírez, José L San Millán, Héctor F Escobar-Morreale.   

Abstract

BACKGROUND: We have evaluated the impact of the reproductive status of morbidly obese women, and of the time elapsed since surgery, on the response of the proinflammatory serum cardiovascular risk marker interleukin-18 (IL-18) to the sustained and marked weight loss achieved after bariatric surgery.
METHODS: Serum IL-18 levels were measured in 33 morbidly obese women before bariatric surgery and after losing at least 15% of the initial weight, irrespective of the time needed to achieve this goal (5 to 33 months).
RESULTS: Patients lost 30.7 +/- 7.8% of the initial weight, with a concomitant reduction of serum IL-18 concentrations (P<0.001). A stepwise multiple regression analysis showed that the percentual decrease in serum IL-18 levels was determined by the interaction between the time elapsed since surgery and the percentual reduction of waist circumference (R2 = 0.333, F = 15.500, beta = 0.577, P<0.001), but not by the individual effects of the time elapsed since surgery, percentual body weight loss, percentual reduction of waist circumference, menopausal status or type of surgical procedure, or by the interaction between the time elapsed since surgery with the percentual body weight loss or with menopausal status.
CONCLUSION: Serum IL-18 levels decrease after bariatric surgery in a time-dependent manner, in relation to the reduction in waist circumference. The fact that the amelioration of the obesity-associated inflammatory process requires time and not only weight loss, might contribute to explain early non-surgical cardiovascular complications of bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18074495     DOI: 10.1007/s11695-007-9202-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  38 in total

1.  Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.

Authors:  Christian P Fischer; Lisbeth B Perstrup; Annika Berntsen; Peter Eskildsen; Bente K Pedersen
Journal:  Clin Immunol       Date:  2005-08-19       Impact factor: 3.969

2.  Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.

Authors:  Yi-fei Zhang; Yi-sheng Yang; Jie Hong; Wei-qiong Gu; Chun-fang Shen; Min Xu; Peng-fei Du; Xiao-ying Li; Guang Ning
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

3.  The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes.

Authors:  I Stuart Wood; Bohan Wang; John R Jenkins; Paul Trayhurn
Journal:  Biochem Biophys Res Commun       Date:  2005-09-21       Impact factor: 3.575

4.  Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.

Authors:  Harvey J Sugerman; Luke G Wolfe; Domenic A Sica; John N Clore
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

5.  Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

Authors:  H-P Kopp; K Krzyzanowska; M Möhlig; J Spranger; A F H Pfeiffer; G Schernthaner
Journal:  Int J Obes (Lond)       Date:  2005-07       Impact factor: 5.095

6.  Weight loss reduces interleukin-18 levels in obese women.

Authors:  Katherine Esposito; Alessandro Pontillo; Myriam Ciotola; Carmen Di Palo; Elisa Grella; Gianfranco Nicoletti; Dario Giugliano
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

7.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Authors:  John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

8.  Years of life lost due to obesity.

Authors:  Kevin R Fontaine; David T Redden; Chenxi Wang; Andrew O Westfall; David B Allison
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

Review 9.  Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review.

Authors:  A Poobalan; L Aucott; W C S Smith; A Avenell; R Jung; J Broom; A M Grant
Journal:  Obes Rev       Date:  2004-02       Impact factor: 9.213

10.  Biliopancreatic diversion for obesity at eighteen years.

Authors:  N Scopinaro; E Gianetta; G F Adami; D Friedman; E Traverso; G M Marinari; S Cuneo; B Vitale; F Ballari; M Colombini; G Baschieri; V Bachi
Journal:  Surgery       Date:  1996-03       Impact factor: 3.982

View more
  7 in total

Review 1.  The immune remodel: Weight loss-mediated inflammatory changes to obesity.

Authors:  Charles L Phillips; Bernadette E Grayson
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

Review 2.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

3.  The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery.

Authors:  José I Botella-Carretero; Manuel Luque-Ramírez; Francisco Alvarez-Blasco; Roberto Peromingo; José L San Millán; Héctor F Escobar-Morreale
Journal:  Obes Surg       Date:  2008-03-19       Impact factor: 4.129

4.  Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease.

Authors:  José I Botella-Carretero; José A Balsa; Clotilde Vázquez; Roberto Peromingo; Manuela Díaz-Enriquez; Héctor F Escobar-Morreale
Journal:  Obes Surg       Date:  2008-10-02       Impact factor: 4.129

5.  Inflammatory markers and bariatric surgery: a meta-analysis.

Authors:  S Raghavendra Rao
Journal:  Inflamm Res       Date:  2012-05-16       Impact factor: 4.575

6.  Beneficial changes on plasma apolipoproteins A and B, high density lipoproteins and oxidized low density lipoproteins in obese women after bariatric surgery: comparison between gastric bypass and sleeve gastrectomy.

Authors:  J M Gómez-Martin; J A Balsa; E Aracil; M Cuadrado-Ayuso; M Rosillo; G De la Peña; M A Lasunción; H F Escobar-Morreale; J I Botella-Carretero
Journal:  Lipids Health Dis       Date:  2018-06-20       Impact factor: 3.876

Review 7.  Impact of Bariatric Surgery on Adipose Tissue Biology.

Authors:  Óscar Osorio-Conles; Josep Vidal; Ana de Hollanda
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.